HIV-1 Infection
Showing 1 - 25 of 178
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
PREPARE (A5361s) Substudy of REPRIEVE (A5332)
Active, not recruiting
- HIV-1 Infection
- Pitavastatin
- Placebos
-
Birmingham, Alabama
- +32 more
Dec 7, 2022
HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)
Active, not recruiting
- HIV-1 Infection
- Oral Lenacapavir
- +3 more
-
Los Angeles, California
- +22 more
Nov 4, 2022
HIV-1 Infection Trial in Worldwide (DOR/ISL)
Active, not recruiting
- HIV-1 Infection
-
Washington, District of Columbia
- +16 more
Oct 13, 2022
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
HIV-1 Infection Trial in Kaohsiung City, Taiwan (UB-421, chidamide)
Recruiting
- HIV-1 Infection
- UB-421
- chidamide
-
Kaohsiung City, Taiwan, TaiwanKaohsiung Veterans General Hospital
Aug 25, 2022
HIV-1 Infection Trial in Kaohsiung City (UB-421 SC(dB4C7C22-6 mAb))
Recruiting
- HIV-1 Infection
- UB-421 SC(dB4C7C22-6 mAb)
-
Kaohsiung City, TaiwanKaohsiung Veterans General Hospital
May 12, 2022
HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)
Withdrawn
- HIV-1 Infection
- Dolutegravir plus lamivudine
-
Caba, Buenos Aires, Argentina
- +1 more
Apr 5, 2022
HIV-1 Infection Trial in Worldwide (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or
Active, not recruiting
- HIV-1 Infection
- elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
-
Birmingham, Alabama
- +29 more
Jan 24, 2022
HIV-1 Infection Trial in Toulouse (Peripheral blood and intestinal biopsies will be collected)
Completed
- HIV-1 Infection
- Peripheral blood and intestinal biopsies will be collected
-
Toulouse, France
- +1 more
Dec 30, 2021
HIV-1 Infection Trial in France (Samplings)
Recruiting
- HIV-1 Infection
- Samplings
-
Clamart, France
- +6 more
Jan 4, 2022
HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,
Completed
- HIV-1 Infection
- Dolutegravir
- +2 more
-
All The Regions Of The Country (40 Centers), France(unnamed)
Jan 3, 2022
HIV-1 Infection Trial in Beijing (SHR2150;Placebo)
Completed
- HIV-1 Infection
- SHR2150;Placebo
-
Beijing, Beijing, ChinaBeijing youan Hospital,Capital medical university
Dec 24, 2021